Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Completed · Phase 1 · Has a placebo group

Conditions studied: Systemic Lupus Erythematosus

In brief

The purpose of thie study is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of belimumab (LymphoStat-B™)in subjects with SLE.

Key facts

Study ID

NCT00657007

Run by

Human Genome Sciences Inc.

People needed

70

Starts

2002-02-01

Expected to finish

2003-03-01

Last updated by the study team

2013-08-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• University of Southern California — Los Angeles, California, United States
• University of California-Los Angeles — Los Angeles, California, United States
• Washington Hospital Center — Washington D.C., District of Columbia, United States
• Northwestern University Medical School — Chicago, Illinois, United States
• Rush-Presbyterian-St Luke's Medical Center — Chicago, Illinois, United States
• The University of Chicago Hospital — Chicago, Illinois, United States
• The University of Michigan Health System — Ann Arbor, Michigan, United States
• SUNY Downstate Medical Center — Brooklyn, New York, United States
• North Shore University Hospital — Manhasset, New York, United States
• Hospital for Joint Diseases — New York, New York, United States
• The University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
• Duke University — Durham, North Carolina, United States
• Wake Forest University School of Medicine — Winston-Salem, North Carolina, United States
• Oklahoma Medical Research Foundation — Oklahoma City, Oklahoma, United States
• University of Pittsburgh School of Medicine — Pittsburgh, Pennsylvania, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• University of Texas Southwestern Medical Center at Dallas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.